CBNA(CBNA)
CBNA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $74M | $70M |
| Low | $72M | $68M |
| High | $75M | $71M |
| EBITDA Avg | $23M | $22M |
| Low | $23M | $22M |
| High | $24M | $23M |
| EBIT Avg | $23M | $21M |
| Low | $22M | $21M |
| High | $23M | $22M |
| Net Income Avg | $31M | $25M |
| Low | $29M | $25M |
| High | $33M | $25M |
| EPS Avg | $4.70 | $3.84 |
| Low | $4.38 | $3.82 |
| High | $5.00 | $3.87 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $20M | $17M | $17M | $17M | $18M | $18M |
| Low | $19M | $16M | $15M | $16M | $16M | $16M |
| High | $21M | $19M | $18M | $19M | $20M | $20M |
| EBITDA Avg | $6M | $5M | $5M | $5M | $6M | $6M |
| Low | $6M | $5M | $5M | $5M | $5M | $5M |
| High | $7M | $6M | $6M | $6M | $6M | $6M |
| EBIT Avg | $6M | $5M | $5M | $5M | $6M | $6M |
| Low | $6M | $5M | $5M | $5M | $5M | $5M |
| High | $7M | $6M | $6M | $6M | $6M | $6M |
| Net Income Avg | $9M | $7M | $6M | $6M | $6M | $7M |
| Low | $8M | $6M | $5M | $6M | $6M | $6M |
| High | $10M | $8M | $7M | $7M | $7M | $7M |
| EPS Avg | $1.35 | $1.02 | $0.89 | $0.95 | $0.99 | $1.01 |
| Low | $1.15 | $0.90 | $0.79 | $0.84 | $0.88 | $0.90 |
| High | $1.55 | $1.14 | $1.00 | $1.07 | $1.11 | $1.14 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |